Medical Devices Startups

Capsida Biotherapeutics develops engineered gene therapies for rare and common neurological and ocular diseases using an AAV capsid platform that enables improved brain and retinal delivery compared to naturally occurring capsids. The company targets both central nervous system and ophthalmology conditions across all ages.

1 investor

Capsule endoscopy medical device that captures high-resolution images of the digestive system to diagnose gastrointestinal conditions. The swallowable capsule is used to evaluate obscure bleeding, inflammatory diseases, and other GI disorders.

1 investor

Caption Care delivers cardiac ultrasounds (echocardiograms) performed in clinics or patients' homes using AI-guided imaging and interpretation technology, enabling earlier detection of heart disease. It serves healthcare organizations and their members by identifying at-risk patients, scanning them, and generating cardiologist-reviewed clinical reports with optional care management services.

1 investor

Captive Radiology designs and manages imaging partnerships for healthcare providers, offering mobile and in-house radiology programs along with operations management, project management, staffing, equipment sourcing, and quality assessment. It serves large physician practices and hospitals/health systems, particularly specialty groups such as urology and orthopaedics.

1 investor

Cara Care builds a digital therapy program for irritable bowel syndrome and other digestive problems, combining gastroenterology and psychological research into a personalized treatment. Founded by physicians and certified as a medical device in Europe, the company is based in Berlin, Germany.

1 investor

Caravel Autism Health provides evaluation, diagnosis, and data-driven therapy programs for children with autism, supported by their proprietary PathTap™ outcomes platform for clinical progress tracking and analysis. The organization serves families navigating autism care with evidence-based treatment approaches.

1 investor

Carbometrics is developing i-CAM, a continuous metabolic monitor for cardiopulmonary bypass and organ perfusion circuits used in medical procedures. The product is aimed at clinical settings, with the company engaging clinical collaborators and OEM partners.

1 investor

CardiaCare develops a closed-loop wearable device for non-invasive nerve stimulation treatment of cardiac and central nervous system conditions, featuring continuous monitoring and AI-based alerts for remote patient management. The company is a clinical-stage digital therapeutic platform combining medical device and software capabilities.

1 investor

Cardihab provides a digital cardiac rehabilitation platform that uses smartphone apps and web portals to enable clinicians to deliver remote and flexible rehabilitation services to patients with heart disease.

1 investor

Cardioline develops diagnostic cardiology and telemedicine solutions, including ECG devices and telecardiology tools, for healthcare providers and clinicians. With over 60 years of experience, it offers a modular product range covering various healthcare settings across the patient care journey.

1 investor

CardioMech develops a transcatheter mitral valve repair system (MVRS) that delivers artificial chords via a transfemoral, transseptal catheter approach to treat degenerative mitral regurgitation on a beating heart. The device targets heart disease patients as a less-invasive alternative to open-heart surgery and is currently for investigational use only.

1 investor

Philips provides cardiac monitoring and diagnostic solutions that connect patient monitoring across hospital and home settings. The company serves healthcare providers and patients through ECG solutions, ambulatory monitoring, and implantable device management across the cardiac care continuum.

1 investor

CardioSecur is a Germany-based company that develops app-based ECG technology for medical professionals and corporate clients, converting conventional 12-lead ECG systems into 3D-imaging diagnostic tools. The company's solutions are designed to enable lower-risk clinical procedures with higher patient efficacy.

1 investor

Cardiovalve develops a transcatheter valve replacement system designed to fit both mitral and tricuspid anatomies via transfemoral delivery, avoiding open heart surgery. The device targets structural heart disease and is currently restricted to research use.

1 investor

CardioVia develops ViaOne, an FDA-cleared epicardial access device that creates a pathway to the heart's surface using a blunt tip with a concealed needle to reduce heart perforation risk. The device supports cardiac interventions such as arrhythmia ablation, epicardial lead and pacemaker implantation, and targeted drug, stem cell, and gene delivery.

1 investor

Cardiovolt is an AI platform that analyzes standard 12-lead ECG signals and images to detect subtle digital biomarkers, predicting cardiovascular disease risk before symptoms appear. It is aimed at healthcare systems and clinical settings for earlier cardiovascular risk assessment, though the company states it is not yet ready for clinical use.

1 investor

Care Fertility is the UK's leading fertility treatment provider offering personalized IVF and reproductive treatments across clinics in the UK, Ireland, Spain, and the United States. The company combines advanced reproductive science with compassionate care to help people build families through assisted reproduction.

1 investor

Carebot develops artificial intelligence software that assists physicians in detecting and interpreting medical imaging findings, aiming to reduce diagnostic errors and physician workload. The company serves hospitals and medical imaging departments across Europe, with a focus on equal diagnostic quality across urban and remote regions.

1 investor

Carelane provides a unified infrastructure platform for managing clinical trials, designed to reduce complexity and accelerate research timelines while maintaining regulatory compliance. The platform serves research organizations and clinical trial sites by consolidating tools and workflows that are typically scattered across multiple vendors.

1 investor

CareMedi is a South Korean medical device company, founded as a university spinout from Sogang University in 2015, that develops wearable drug-delivery devices based on its proprietary plate electroosmotic pump (PEOP) technology. Its main product is a patch-type insulin pump for type 1 and type 2 diabetes patients, and it plans to expand into artificial pancreas systems and AI-based glucose management.

1 investor

CRH Anesthesia is an anesthesia service provider that staffs medical facilities with anesthesiologists and Certified Registered Nurse Anesthetists (CRNAs) across the United States. The company serves outpatient surgery centers, ambulatory surgical centers (ASCs), and gastroenterology practices.

1 investor

CareTech Human develops a remote urinalysis device (UroWell) using optical sensing, microchips, and cloud processing to let urologists monitor and assess patient condition without frequent office visits. Originally developed in Ukraine and incubated at Cornell University, the company builds passive health monitoring technology for urological care.

1 investor

Carez AI develops synthetic medical imaging powered by AI to support diagnostic and interventional radiology applications. The company targets healthcare providers and medical imaging professionals seeking advanced diagnostic tools.

1 investor

CARI Health develops diagnostic solutions for medication monitoring, specifically focused on personalized methadone dosing for opioid use disorder treatment. The company combines clinical expertise with advanced diagnostic technology to address the opioid crisis.

1 investor